Mandy Fraessdorf

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

Arun J. Sanyal, Pierre Bédossa, Mandy Fraessdorf et al. · New England Journal of Medicine · 2024 · 423 citations

Medicine, Pharmacology, Pharmacotherapy +17

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure

Jeff S. Healey, Martina Brueckmann, John W. Eikelboom et al. · Thrombosis and Haemostasis · 2014 · 230 citations

Medicine, Perioperative Medicine, Surgery +17

Dabigatran Compared with Warfarin in Patients with Atrial Fibrillation and Symptomatic Heart Failure: A Subgroup Analysis of the RE-LY Trial

Jorge Ferreira, Michael D. Ezekowitz, Stuart J. Connolly et al. · European Journal of Heart Failure · 2013 · 96 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER ^® , RE-COVER™ II, and RE-MEDY™

Samuel Z. Goldhaber, Henry Eriksson, Ajay K. Kakkar et al. · Vascular Medicine · 2016 · 90 citations

Medicine, Hematology, Pharmacotherapy +14

Efficacy and augmentation during 6months of double-blind pramipexole for restless legs syndrome

Birgit Högl, Diego Garcı́a-Borreguero, Claudia Trenkwalder et al. · Sleep Medicine · 2011 · 85 citations

Medicine, Neurology, Pharmacotherapy +4